Background: Nephrotic syndrome (NS) is a kidney disease predominantly present in children
Introduction
In children, nephrotic syndrome (NS) is defined as protein excretion of more than 40 mg/m2/h or a first-morning urine protein/creatinine of 2-3 mg/mg creatinine or greater [1] . The childhood NS has a male predominance (74%). The mean age of disease onset was 4.43 ± 2.7 years, with patients having onset of ≤ 6 years constituting 81% of patients [2] . Idiopathic nephrotic syndrome (INS) is the most popular form of childhood NS, representing more than 90% of cases between 1 to 10 years of age and 50% after 10 years of age [3] .
Subjects with minimal change disease (MCD)
have a 95% response rate to steroids, however, 75% will relapse and 50% (frequent relapsers or steroid dependent subjects) will demand higher and prolonged doses of steroids thus increasing the risk of adverse effects [4] . SRNS defined as patients who fail to enter remission after 8 weeks of corticosteroid treatment they are at significantly higher risk for development of complications of the disease, as well as progression of the disease to chronic kidney disease (CKD) or end stage renal disease (ESRD) [5] . Castleman's disease, and therapeutic agents like interferon favors this hypothesis. Altered Tlymphocyte responses could result in the production of a permeability factor that interferes with the expression, function, or both, of key podocyte proteins to cause proteinuria. The podocyte target of such a putative factor is, however, unclear [6] . Third; a higher rate of certain gene polymorphisms among nephrotic patients than controls suggest the existence of disease susceptibility genes [7] .
Podocin (NPHS2), the protein product of NPHS2 gene located on chromosome 1, is a member of stomatin protein family. Podocin is exclusively expressed in the podocytes and localizes at the insertion of the slit membrane. Due to its similarity to stomatin, it is believed that podocin forms a hairpin like structure with intracellular NH2-and COOH-termini [8] .
Several groups from European and Middle Eastern populations reported that near 10-30% of sporadic SRNS was due to NPHS2 gene mutations [9] . The incidence of NPHS2 mutations was 25% in cases of sporadic SRNS in an Egyptian study [10] . For most patients, no curative treatment is available.
The most frequent renal histologic feature of SRNS is focal segmental glomerulosclerosis (FSGS). Moreover, in patients with FSGS, the risk of recurrence after kidney transplantation is estimated to be about 11% -50%, an event that again leads to terminal renal failure [11] . FSGS associated with NPHS2 mutation is uniformly steroid resistant and generally shows poor response to cyclosporine A (CSA) [12] . All the 20 children with SRNS were biopsy proved FSGS.
Table (1) showed that the mean values of potassium and sodium were non-significant while pyuria, hematuria, albumin in urine, urine 24h
protein, urine protein/creatinine ratio, cholesterol, urea and creatinine were significantly higher among cases than controls, but serum albumin was significantly lower among cases than controls. Table ( 2) showed that the mean value of serum potassium was significantly lower among steroid responders (minimal change disease) and that albumin in urine was significant higher among non-responders (focal segmental glomerulosclerosis) while pyuria, hematuria, urine 24h protein, protein/ceatinine ratio, serum sodium, albumin, cholesterol, urea and creatinine were nonsignificant. This study showed that all cases and controls had 100% frequencies for GG genotype and G allele as no gene mutation was detected among all subjects.
Our results were matching with Reiterova et al., [19] as The R229Q polymorphism has a lower frequency among Africans, African-Americans, and Asians (zero to 1.5%). According to Machuca et al., [20] the highest frequency of R229Q has been reported in Chileans and Argentineans (7.3%). Also, Lipska et al., [21] reported that NPHS2 mutations were found to be in of higher prevalence among SRNS patients of the Polish population. Tryggvason et al., [22] [24] .
Coming to the genetic results found in this study, the polymorphism R229Q was found in 0% of cases. Several studies did not report any polymorphism in SRNS [18] , however, higher percent of this polymorphism was found by many other studies [18] . In addition, The polymorphism R229Q was absent among SSNS and SRNS subcategories a finding which was detected by Landau et al. [25] who did not find any polymorphisms in SSNS, as well as Lahdenkari et al., [26] and Caridi et al., [27] . Our results concerning the absence of the NPHS2 R229Q
variant in the present study could be also explained by the small sample size of the study and different ethnic population included (Egyptian subjects).
RECOMMENDATION:
From the results of this study we recommend additional studies with larger sample size, and preferably with the cooperation of multiple centers to further evaluate the response of children resistant to steroid, as regards various available modalities of therapy so as to reach final conclusion to the important question; are we justified to stop any further medications in cases having such mutations, to minimize side effects?
